share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:拟议出售证券
美股SEC公告 ·  11/14 14:02

Moomoo AI 已提取核心信息

Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.
arcutis biotherapeutics, Inc. 的官员Burnett Patrick计划于2024年11月14日出售69,126股普通股,总市场价值约为711,615美元。这些待售股份是通过限制性股票归属在多个日期获得的,包括2024年8月1日、2024年8月17日、2024年8月18日和2024年11月1日,另外还有通过股票期权行使于2024年1月12日获得的股份。证券直接从arcutis biotherapeutics获得。在过去的三个月中,Burnett总共出售了17,169股,产生了147,892美元的毛收益。
arcutis biotherapeutics, Inc. 的官员Burnett Patrick计划于2024年11月14日出售69,126股普通股,总市场价值约为711,615美元。这些待售股份是通过限制性股票归属在多个日期获得的,包括2024年8月1日、2024年8月17日、2024年8月18日和2024年11月1日,另外还有通过股票期权行使于2024年1月12日获得的股份。证券直接从arcutis biotherapeutics获得。在过去的三个月中,Burnett总共出售了17,169股,产生了147,892美元的毛收益。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息